Industry relief over drugs and water quality compromise in EU
This article was originally published in SRA
Executive Summary
There is relief for drug developers in the EU as plans to place three commonly used pharmaceuticals on a priority list of substances affecting water quality have been put on hold. Placing them on the priority list would have resulted in the substances being subjected to strict environmental quality standards or even being phased out were they ultimately to have been deemed hazardous1-4.